Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Andreone

Showing results (11-20 of 204) with videos related to

Pageof 21
Sort By:
Journal of Hepatology|December 26, 2016
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir?Ranka Vukotic, Fabio Conti, Pietro Andreone
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 9, 2014
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis CRanka Vukotic, Nesrine Gamal, Pietro Andreone
Journal of Clinical and Translational Hepatology|September 11, 2015
Update on Alcohol and Viral HepatitisStefano Gitto, Giovanni Vitale, Erica Villa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 22, 2020
The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher diseaseFabio Nascimbeni, Simonetta Lugari, Pietro Andreone, et al.
Metabolites|March 3, 2018
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical PerspectivesStefano Gitto, Filippo Schepis, Pietro Andreone, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 3, 2012
Menopause, and not age, is a critical factor associated with a worse response to antiviral therapy in women affected by chronic hepatitis CStefano Gitto, Aimilia Karampatou, Pietro Andreone, et al.
Expert Review of Gastroenterology & Hepatology|October 31, 2017
The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectivesStefano Gitto, Valeria Guarneri, Alessandro Sartini, et al.
Hepatic Medicine : Evidence and Research|August 7, 2023
Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?Alessandra Bartoli, Carmela Cursaro, Hajrie Seferi, et al.
Journal of Hepatology|December 14, 2023
Reply to: "5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial. Was an accurate statistical analysis performed?"Ranka Vukotic, Roberto Di Donato, Jaime Bosch, et al.
Annals of Hepatology|February 5, 2016
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfectionFabio Conti, Giovanni Vitale, Carmela Cursaro, et al.
Pageof 21

Showing results (11-20 of 204) with videos related to

Sort By:
Pageof 21
Journal of Hepatology|December 26, 2016
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir?Ranka Vukotic, Fabio Conti, Pietro Andreone
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 9, 2014
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis CRanka Vukotic, Nesrine Gamal, Pietro Andreone
Journal of Clinical and Translational Hepatology|September 11, 2015
Update on Alcohol and Viral HepatitisStefano Gitto, Giovanni Vitale, Erica Villa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 22, 2020
The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher diseaseFabio Nascimbeni, Simonetta Lugari, Pietro Andreone, et al.
Metabolites|March 3, 2018
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical PerspectivesStefano Gitto, Filippo Schepis, Pietro Andreone, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 3, 2012
Menopause, and not age, is a critical factor associated with a worse response to antiviral therapy in women affected by chronic hepatitis CStefano Gitto, Aimilia Karampatou, Pietro Andreone, et al.
Expert Review of Gastroenterology & Hepatology|October 31, 2017
The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectivesStefano Gitto, Valeria Guarneri, Alessandro Sartini, et al.
Hepatic Medicine : Evidence and Research|August 7, 2023
Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?Alessandra Bartoli, Carmela Cursaro, Hajrie Seferi, et al.
Journal of Hepatology|December 14, 2023
Reply to: "5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial. Was an accurate statistical analysis performed?"Ranka Vukotic, Roberto Di Donato, Jaime Bosch, et al.
Annals of Hepatology|February 5, 2016
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfectionFabio Conti, Giovanni Vitale, Carmela Cursaro, et al.
Pageof 21